Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling - Institut Pasteur Access content directly
Journal Articles Annals of the Rheumatic Diseases Year : 2018

Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Abstract

We read with great interest the paper of Giannelou et al1 reporting, for the first time, the efficacy of tumour necrosis factor (TNF) inhibitors in sideroblastic anaemia with immunodeficiency, fevers and developmental delay (SIFD). These authors also demonstrated high levels of interleukin (IL)-6, IL-12p40, IL-18, interferon (IFN)-γ and IFN-induced chemokines (IP-10 and MIG) in two patients. Herein, we wish to highlight that an activation of the type I IFN pathway may also be observed in SIFD [...]

Domains

Immunology
Fichier principal
Vignette du fichier
annrheumdis-2018-213745.full.pdf (125.31 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-01819255 , version 1 (20-06-2018)

Licence

Copyright

Identifiers

Cite

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, et al.. Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling. Annals of the Rheumatic Diseases, 2018, ⟨10.1136/annrheumdis-2018-213745⟩. ⟨pasteur-01819255⟩
45 View
139 Download

Altmetric

Share

Gmail Facebook X LinkedIn More